Search

The Health and Biomedical Sciences International Advisory Council (HBMS IAC) serves the following functions:

  • Shares perspectives and insights
  • Advises Singapore on major global trends in biomedical research and industry
  • Critiques and advises Singapore on its BMS initiatives


Chairman


Sir Richard Sykes

Chairman, HBMS IAC (2000-)
Chairman, Imperial College Healthcare NHS Trust (2011-)


Members


Sir Leszek K Borysiewicz

Member, HBMS IAC (2008 - )
Vice Chancellor, University of Cambridge, (2010-)



Dr Elias Zerhouni

Member, HBMS IAC (2013-)
President , Global R&D Sanofi



 
Dame Sally C Davies

Member, HBMS IAC (2008-)
Chief Medical Officer for England and Chief Scientific Advisor to Department of Health UK



 
Prof Warwick Anderson

Member, HBMS IAC
Secretary-General, Human Frontier Science Program



Dr Patrick Aebischer

Member, HBMS IAC (2013-)
President EPFL and Board member of Nestle Health Science


 

Lord Ara Darzi

Member, HBMS IAC (2013-)
Chair of Surgery and Director of the Institute for Global Health Innovation, Imperial College



Sir Andrew Witty

Member, HBMS IAC (2013-)
CEO, GlaxoSmithKline



Dr Tadataka Yamada

Member, HBMS IAC (2006-)
Venture Partner, Frazier Healthcare Partners




Professor Rolf Zinkernagel

Member, HBMS IAC (2006-)
Professor Emeritus of Experimental Immunology, University of Zurich



Professor Detlev Ganten

Member, HBMS IAC (2011-)
President, World Health Summit and Chairman, Charite Foundation



Sir John Savill

Member, HBMS IAC (2011-)
Chief Executive, UK Medical Research Council (2010-)



 Mr William Hawkins

Member, HBMS IAC (2013-)
Lead Director, Immucor (2011-)



Dr Jeremy Farrar

Member, HBMS IAC (2013-)
Director, Wellcome Trust



 
Prof Victor Dzau

Member, HBMS IAC (2016-)
President, US Institute of Medicine


Prof Keiji Fukuda

Member, HBMS IAC (2017-)
Clinical Professor, School of Public Health of the Hong Kong University




Dr Carl Firth

Member, HBMS IAC (2017-)
Chief Executive Officer, ASLAN Pharmaceuticals



 
Ms Deborah Ann Henretta

Member, HBMS IAC (2017-)
Senior Advisor, SSA & Co



Dr John Jeans

Member, HBMS IAC (2017-)
Chairman, Imanova, UK Biocentre and Edinburgh Molecular Group



Mr Lu Yoh-Chie

Member, HBMS IAC (2017-)
Former Chairman and Founder, Biosensors International Group



Mr Jean-Luc Butel

Member, HBMS IAC (2017-)
President, K8 Global





Emeritus Members


Dr David Baltimore

Member, HBMS IAC (2000-2006)
Robert A. Millikan Professor of Biology California Institute of Technology(2007-)
President, California Institute of Technology, USA (1997-2006)

1975 Winner of the Nobel Prize in Physiology or Medicine
President of Rockefeller University, USA (1990-1991)

Founding Director, Whitehead Institute for Biomedical Research at MIT, USA
(1982-1990)


Dr Samuel Barondes

Member, HBMS IAC (2001-2004)
Chair, Board of Scientific Counselors, National Institute of Mental Health 

Director, Center for Neurobiology and Psychiatry, University of California, San Francisco (UCSF), USA

Chairman, Dept of Psychiatry & Director, Langley Porter Psychiatric Institute, UCSF, USA (1986-1993)


Dr Alan Bernstein

Member, HBMS IAC,(2003-2005)
Executive Director, Global HIV Vaccine Enterprise
President, Canadian Institutes of Health Research, Canada (2000-2007)

Director of Research, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Canada (1994-2000)


Dr Colin Blakemore

Member, HBMS IAC (2005-2007)

Chairman, A*STAR - Duke-NUS Graduate Medical School Neuroscience Research Partnership, Singapore (2007-)

Chief Executive, Medical Research Council, UK (2003-2007)
President, British Neuroscience Association (1997-2000)
President, British Association for the Advancement of Science (1997-1998)


Professor Sir Philip Cohen

Member, HBMS IAC (2006-)

Director & Royal Society Research Professor, School of Life Sciences, University of Dundee (1984-)


Dr Stanley N. Cohen

Member, HBMS IAC (2000-2004)
Previous Chairman, Department of Genetics, Stanford University

Kwoh-Ting Li Professor of Genetics and Professor of Medicine, Stanford University (USA)



Dr David I. Hirsh

Member, HBMS IAC (2000-2003)
Executive Vice President for Research, Columbia University, USA (2003-)

Chairman, Dept of Biochemistry and Molecular Biophysics, College of Physicians and Surgeons, Columbia University (1990-2003)

Interim Dean for Research, Faculty of Medicine, Columbia University (2000-2001)
Executive Vice President & Director of Research, Synergen, Inc (1984-1990)


Dr Leland Hartwell

Member, HBMS IAC (2001-2007)
President & Director, Fred Hutchinson Cancer Research Center, USA (1997-)
2001 Winner of the Nobel Prize in Physiology or Medicine


Dr Philippe Kourilsky

Member, HBMS IAC (2000-2006)
Chairman, Singapore Immunology Network (SIgN) (2006-)
Chair of Molecular Immunology, College de France, France (1998-)

General Director, Institut Pasteur, France (2000-2004)
Head of Research, Pasteur-Mérieux-Connaught (now Aventis-Pasteur),
France (1993-1996)


Dr Richard Lerner

Member, HBMS IAC (2003-2005)
President, The Scripps Research Institute, USA (1986-)

Chairman, Department of Molecular Biology, The Scripps Research Institute, USA (1982-1986)


Dr Susan Lindquist

Member, HBMS IAC (2003-2005)
Member, Whitehead Institute & Professor of Biology, MIT (USA)
Director, Whitehead Institute, MIT (2001-2004)

Albert D. Lasker Professor of Medical Sciences, Dept of Molecular Genetics & Cell Biology, University of Chicago (1999-2001)


Dr Paul A. Marks

Member, HBMS IAC (2000-2003)
President Emeritus, Memorial Sloan-Kettering Cancer Center, USA

President & Chief Executive Officer, Memorial Sloan-Kettering Cancer Center
(1980-1999)

VP for Health Sciences & Director, Comprehensive Cancer Center, (1973-1980) & Dean, Faculty of Medicine (1970-1973), Columbia University


Dr John Mendelsohn

Co-Chairman, HBMS IAC (2004-2007)
President, University of Texas M.D. Anderson Cancer Center, USA (1996-)

Chairman, Department of Medicine, Memorial Sloan Kettering Cancer Center,
USA (1985-1996)


Dr Alan Munro

Member, HBMS IAC (2000-2003)

Former Master of Christ’s College, University of Cambridge, UK
Master of Christ's College, University of Cambridge (1995-2002)

Founder, Cantab Pharmaceuticals plc (1989-1995)


Sir Keith Peters

Member, HBMS IAC (2000-2004)
Chairman, A*STAR Graduate Academy International Advisory Panel

Regius Professor of Physics, School of Clinical Medicine, University of Cambridge,
UK (1987-2005)

Head, School of Clinical Medicine & Honorary Consultant Physician, Addenbrooke's NHS Trust, University of Cambridge


Professor Sir George Radda

Member, HBMS IAC (2003-2005)
Chairman, Biomedical Research Council, A*STAR
Chairman, Singapore Bioimaging Consortium (2005-)

Professor and Head, Department of Physiology, Anatomy and Genetics,
University of Oxford (2005-)


Dr John Reed

Member, HBMS IAC (2004-2006)
President & CEO, The Burnham Institute, USA (2002-)
Scientific Director, The Burnham Institute, USA (1995-2002)

Deputy Director, Burnham Institute Cancer Center, USA (1994-2002)
Scientific Co-Founder of IDUN Pharmaceuticals (1993) and GMP/Diagnostics


Dr John Shine

Member, HBMS IAC (2000-2003)
Executive Director, Garvan Institute of Medical Research, Australia (1990-)
Chairman, Australian National Health & Medical Researh Council

Chairman, Australian Genome Research Facility (2000-2003)
President (1986-1987) & DIrector of Research (1984-1986), California Biotechnology Inc.


Dr Axel Ullrich

Member, HBMS IAC (2000-2004)

Research Director, Singapore OncoGenome Project, Centre for Molecular Medicine, A*STAR (2004-)

Director, Molecular Biology, Max-Planck-Institute for Biochemie,
Germany (1988-)

Founder of SUGEN Inc., USA (1991),
Axxima Pharmaceuticals AG, Germany & U3 Pharma AG, Germany


Dr Hans Wigzell

Member, HBMS IAC (2000-2004)
Director, Centre for Medical Innovations, Karolinska Institute, Sweden (2004-)
President, Karolinska Institute (1995-2003)

Chief Scientific Advisor to Swedish Government (1999-)
Chairman, WHO-UNAIDS Vaccine Advisory Committee (2002)
Director General, National Bacteriological Laboratory, Sweden (1988)


Dr Peter Gruss

Member, HBMS IAC (2004-2010)
President, Max Planck Society, Germany (2002-)
Honorary Professor, University of Göttingen, Germany (1990-)


Dr John Bell

Member, HBMS IAC, (2002-2010)
Regius Professor of Clinical Medicine, University of Oxford, UK (2002-)
Founded Oxford University's Wellcome Trust Centre for Human Genetics (1993)

Founder/Founding Director of Powderject (1993), Oxagen (1997) and Avidex (1999)


Sir Paul Nurse

Member, HBMS IAC (2010-)
President, The Royal Society UK


Dr Helen Hobbs

Member, HBMS IAC (2006-2013)
Director, Eugene McDermott Center Human Growth and Development
University of Texas Southwestern Medical Center (USA) (2000-)

Investigator, Howard Hughes Medical Institute (2002-)
Chief, Division of Medical Genetics, University of Texas Southwestern (UTSW) Medical Center (1987-)


Dr Harriet Wallberg-Henriksson

Member, HBMS IAC (2004-2013)
President, Karolinska Institute, Sweden (2004-)
Dean and Chairwoman, Board of Research, Sweden (1999-2001)

Secretary General (2001-2003), and Asst. Secretary General (1996-1998), Swedish Research Council Scientific Council for Medicine


Dr Suzanne Cory

Member, HBMS IAC (2003-2013)
President, Australian Academy of Science (2010-)

Professor, Molecular Genetics of Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Australia (1996-)



 
Dr Jack Dixon

Member, HBMS IAC (2010-2014)

Professor of Pharmacology, Professor of Cellular and Molecular Medicine, Professor of Chemistry and Biochemistry, University of California, San Diego

Vice President and Chief Scientific Officer, Howard Hughes Medical Institute
(2007-2013)




Nobel Laureate Dr Sydney Brenner

Member, HBMS IAC (2000-2016)
Scientific Advisor to A*STAR Chairman

Distinguished Professor, the Salk Institute for Biological Sciences, US